Literature DB >> 8195313

Long-term persistence of selective IgA deficiency in healthy adults.

S Koskinen1, H Tölö, M Hirvonen, J Koistinen.   

Abstract

A follow-up study of 204 healthy blood donors with IgA deficiency, identified between 1971 and 1980, was carried out. Sera were initially screened by a double diffusion method and 182 were retested by a more sensitive haemagglutination inhibition method. A reexamination was performed in 1990 and, again, in 1991-1992 using an enzyme immunoassay (EIA) developed for the measurement of very low concentrations of IgA. The median follow-up period was 19 years, and in 159 (78%) subjects no serum IgA could be detected in any of the measurements. In 42 (21%) subjects, serum IgA was detectable (> 0.18 mg/L), but the level was below the lower limit of the reference range for adults (800 mg/L) and remained relatively constant. Three subjects showed minute amounts of IgA by EIA (0.2-3 mg/L) in one of the follow-up samples in 1990-1992, but the level was below the detection limit of the EIA (0.05 mg/L) in the other sample. Thus, not only does primary IgA deficiency appear to be permanent, but also lower than normal serum IgA levels remain the same in healthy adults.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195313     DOI: 10.1007/bf01541344

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  21 in total

1.  Preparation of IgA-deficient platelets.

Authors:  E M Sloand; S M Fox; S M Banks; H G Klein
Journal:  Transfusion       Date:  1990-05       Impact factor: 3.157

2.  Selective IgA deficiency in Japanese blood donors: frequency and statistical analysis.

Authors:  T Kanoh; T Mizumoto; N Yasuda; M Koya; Y Ohno; H Uchino; K Yoshimura; Y Ohkubo; H Yamaguchi
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

3.  Selective IgA deficiency: presentation of 30 cases and a review of the literature.

Authors:  A J Ammann; R Hong
Journal:  Medicine (Baltimore)       Date:  1971-05       Impact factor: 1.889

4.  A sensitive enzyme immunoassay for the measurement of low concentrations of IgA.

Authors:  M Hirvonen; S Koskinen; H Tölö
Journal:  J Immunol Methods       Date:  1993-07-06       Impact factor: 2.303

5.  IgA content of frozen-thawed-washed red blood cells and blood products measured by radioimmunoassay.

Authors:  P L Yap; E A Pryde; D B McClelland
Journal:  Transfusion       Date:  1982 Jan-Feb       Impact factor: 3.157

6.  The effect of aging on human serum immunoglobulin concentrations.

Authors:  C E Buckley; F C Dorsey
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

7.  Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies.

Authors:  C Cunningham-Rundles; Z Zhou; S Mankarious; S Courter
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

8.  Transitory and persistent IgA deficiency. Reevaluation of 19 pediatric patients once found to be deficient in serum IGA.

Authors:  P W Joller; A K Buehler; W H Hitzig
Journal:  J Clin Lab Immunol       Date:  1981-09

9.  Fluctuating levels of serum IgA in individuals with selective IgA deficiency.

Authors:  C Laschinger; D Gauthier; J P Valet; D H Naylor
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

10.  Clinical heterogeneity and reversibility of selective immunoglobulin A deficiency in 80 children.

Authors:  A Plebani; A G Ugazio; V Monafo; G R Burgio
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321

View more
  12 in total

1.  Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults.

Authors:  S Koskinen; H Tölö; M Hirvonen; J Koistinen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

2.  Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency.

Authors:  A K Knight; T Bingemann; L Cole; C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition.

Authors:  I Vorechovský; A D Webster; A Plebani; L Hammarström
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

4.  The PAX5 gene: a linkage and mutation analysis in candidate human primary immunodeficiencies.

Authors:  I Vorechovský; S Koskinen; R Paganelli; C I Smith; M Busslinger; L Hammarström
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  The significance of IgG subclasses and mannan-binding lectin (MBL) for susceptibility to infection in apparently healthy adults with IgA deficiency.

Authors:  J Aittoniemi; S Koskinen; P Laippala; S Laine; A Miettinen
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

6.  HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID).

Authors:  E G De La Concha; M Fernandez-Arquero; A Martinez; F Vidal; P Vigil; L Conejero; M C Garcia-Rodriguez; G Fontan
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

7.  Reversal of Immunoglobulin A Deficiency in Children.

Authors:  Che Kang Lim; Charlotte Dahle; Kerstin Elvin; Bengt A Andersson; Johan Rönnelid; Erik Melén; Anna Bergström; Lennart Truedsson; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2014-11-05       Impact factor: 8.317

8.  Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey.

Authors:  Caner Aytekin; Nilden Tuygun; Selim Gokce; Figen Dogu; Aydan Ikinciogullari
Journal:  J Clin Immunol       Date:  2012-05-01       Impact factor: 8.317

9.  Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.

Authors:  G B Pier; G Meluleni; J B Goldberg
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.

Authors:  I R Korponay-Szabó; I Dahlbom; K Laurila; S Koskinen; N Woolley; J Partanen; J B Kovács; M Mäki; T Hansson
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.